148 related articles for article (PubMed ID: 171774)
21. [Raised creatine-kinase serum activity: not necessarily a sign of disease].
Snoeck MM
Ned Tijdschr Geneeskd; 2004 Jan; 148(3):154; author reply 155. PubMed ID: 14964030
[No Abstract] [Full Text] [Related]
22. [Clinico-electromyographic analysis of atypical forms of chronic progressive motor neuron diseases].
Gekht BM; Kevish AV
Zh Nevropatol Psikhiatr Im S S Korsakova; 1982; 82(3):25-31. PubMed ID: 7080772
[No Abstract] [Full Text] [Related]
23. [Creatine phosphokinase (CPK)--interpretation of the test results].
Shoji S; Sugita H
Nihon Rinsho; 1973; 31():1808-14. PubMed ID: 4582280
[No Abstract] [Full Text] [Related]
24. Serum creatine phosphokinase and pyruvate kinase in neuromuscular disorders and Duchenne dystrophy carriers.
Seay AR; Ziter FA; Wu LH; Wu JT
Neurology; 1978 Oct; 28(10):1047-50. PubMed ID: 570660
[TBL] [Abstract][Full Text] [Related]
25. Macroglobulinemia with peripheral neuropathy simulating motor neuron disease.
Rowland LP; Defendini R; Sherman W; Hirano A; Olarte MR; Latov N; Lovelace RE; Inoue K; Osserman EF
Ann Neurol; 1982 May; 11(5):532-6. PubMed ID: 6285801
[TBL] [Abstract][Full Text] [Related]
26. [Elevated plasma creatine kinase activity - does it always indicate muscle disease?].
Kierdaszuk B; Kamińska A
Neurol Neurochir Pol; 2012; 46(3):257-62. PubMed ID: 22773512
[TBL] [Abstract][Full Text] [Related]
27. Remediable neuromuscular disorders.
Layzer RB
Prim Care; 1975 Jun; 2(2):235-57. PubMed ID: 178015
[TBL] [Abstract][Full Text] [Related]
28. [Creatine phosphokinase: interpretation of the test results].
Sugita H; Furukawa T; Chiba K
Nihon Rinsho; 1969 Mar; ():Suppl:1072-7. PubMed ID: 4948291
[No Abstract] [Full Text] [Related]
29. Cancer and disorders of motor neurons.
Barron KD; Rodichok LD
Adv Neurol; 1982; 36():267-72. PubMed ID: 7180686
[No Abstract] [Full Text] [Related]
30. Presenile dementia with motor neuron disease -an additional case report-.
Mitsuyama Y; Tobo M
Folia Psychiatr Neurol Jpn; 1981; 35(1):35-42. PubMed ID: 7274869
[TBL] [Abstract][Full Text] [Related]
31. Electrophysiologic studies in the diagnosis and prognosis of motor neuron diseases.
Daube JR
Neurol Clin; 1985 Aug; 3(3):473-93. PubMed ID: 3900681
[TBL] [Abstract][Full Text] [Related]
32. [Motor neuron disease: primary lateral sclerosis and amyotrophic lateral sclerosis].
Martić V
Vojnosanit Pregl; 2000; 57(2):205-8. PubMed ID: 10934934
[TBL] [Abstract][Full Text] [Related]
33. [Benign, focal amyotrophy].
Schnyder H; Meyer M
Schweiz Med Wochenschr; 1991 Feb; 121(6):167-73. PubMed ID: 2008595
[TBL] [Abstract][Full Text] [Related]
34. Motor neuron disease in Nova Scotia.
Murray TJ; Pride S; Haley G
Can Med Assoc J; 1974 Apr; 110(7):814-7. PubMed ID: 4825149
[TBL] [Abstract][Full Text] [Related]
35. Subacute, reversible motor neuron disease.
Tucker T; Layzer RB; Miller RG; Chad D
Neurology; 1991 Oct; 41(10):1541-4. PubMed ID: 1844350
[TBL] [Abstract][Full Text] [Related]
36. Cervical spondylotic radiculopathy producing motor manifestations mimicking primary muscular atrophy.
Dorsen M; Ehni G
Neurosurgery; 1979 Oct; 5(4):427-31. PubMed ID: 534045
[TBL] [Abstract][Full Text] [Related]
37. [Differential diagnosis and atypical subsets of amyotrophic lateral sclerosis].
Pradat PF; Bruneteau G
Rev Neurol (Paris); 2006 Jun; 162 Spec No 2():4S81-4S90. PubMed ID: 17128093
[TBL] [Abstract][Full Text] [Related]
38. Elevation of serum creatine phosphokinase in amyotrophic lateral sclerosis.
Panitch HS; Franklin GM
Neurology; 1972 Sep; 22(9):964-6. PubMed ID: 4673382
[No Abstract] [Full Text] [Related]
39. [Prospects of clinical use of the EMG integration method during isometric tensions with continuous increment].
Laterza A; Nappo A
Riv Neurobiol; 1976; 22(3-4):146-57. PubMed ID: 217070
[No Abstract] [Full Text] [Related]
40. Myasthenic neuromyopathy. An unusual neuromuscular disorder.
Kinoshita M; Nakazato H; Wakata N; Satoyoshi E
Eur Neurol; 1982; 21(1):52-8. PubMed ID: 7094950
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
